is rybelsus a glp-1 RYBELSUS® Mechanism of Action Exclusive ePass – Rybelsus Oral
Description
Saxenda has not been studied in patients with a history of pancreatitis

GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet
Previous Serious Hypersensitivity Reaction: Patients who have had a severe allergic reaction (e.g., anaphylaxis or angioedema) to the specific GLP-1 agonist or any of its ingredients should not take it

At Family Health Care, treatment decisions are always individualized